ADVANCED GASTRIC CARCINOMA
Clinical trials for ADVANCED GASTRIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTRIC CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis early-phase trial tests whether adding ceralasertib to the targeted therapy trastuzumab deruxtecan (DS-8201a) is safe and effective for people with advanced solid tumors that have HER2 mutations. About 51 adults with various cancers (breast, stomach, colon, and others) will …
Matched conditions: ADVANCED GASTRIC CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 09:11 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: ADVANCED GASTRIC CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC